Free Trial

Celldex Therapeutics (CLDX) Insider Trading & Ownership

Celldex Therapeutics logo
$21.72 +0.51 (+2.40%)
As of 12:25 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Celldex Therapeutics (NASDAQ:CLDX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.40%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$308.43K
Number Of
Insiders Selling
(Last 12 Months)
0
Get CLDX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Celldex Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

CLDX Insider Buying and Selling by Quarter

Celldex Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/11/2024Anthony S MarucciCEOBuy11,500$26.82$308,430.00  
(Data available from 1/1/2013 forward)

CLDX Insider Trading Activity - Frequently Asked Questions

4.40% of Celldex Therapeutics stock is owned by insiders. Learn more on CLDX's insider holdings.

The following insider purchased CLDX shares in the last 24 months: Anthony S Marucci ($308,430.00).

Insiders have purchased a total of 11,500 CLDX shares in the last 24 months for a total of $308,430.00 bought.

The following insiders have sold CLDX shares in the last 24 months: Diane C Young ($1,586,700.00), Elizabeth Crowley ($2,870,403.08), Margo Heath-Chiozzi ($1,319,156.33), Richard M Wright ($1,579,579.68), and Samuel Bates Martin ($1,799,982.24).

Insiders have sold a total of 266,332 Celldex Therapeutics shares in the last 24 months for a total of $9,155,821.33 sold.



This page (NASDAQ:CLDX) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners